CAR NKT cells offer a promising novel immunotherapy for solid tumors
- OPACC
- Oct 14, 2020
- 1 min read
Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with cancer.
Comments